Mit week 5 meds
This portfolio will assist you in understanding the actions of the neurotransmitters and details on psychopharmacology. You will complete the Neurotransmitter chart within the provided template, which coincides with the information provided in this unit. Completion of this chart will provide you a better overall understanding of the various neurotransmitters, their actions, effects when dysregulated, and drugs used to agonize or antagonize them.
The entire completed document will be submitted in unit 15 but you are encouraged to work towards completing the corresponding components during the correlating units.
Due Date: Sunday at 11:59 pm EST in unit 15
Suggested Component to Complete for Unit 2
- Neurotransmitter Chart
- Page 2 in the attached document below.
Activity Resources
PMHNP Portfolio for Clinical Practice
Table of Contents NU670 Psychopharmacology and Health promotion Neurotransmitter Chart (Unit 2) Antipsychotics Chart (Unit 7) Antidepressants, Anxiolytics, & Mood Stabilizers Chart (Units 5, 6) Substance Use Resources (Chart links) (Units 11, 13, 14) Additional Resources List
|
Neurotransmitters Chart |
|||||||
|
Function (Excitatory or Inhibitory) |
Locations |
Receptors |
Effects of Deficient |
Effects of Surplus |
Agonist Drug |
Antagonist Drug |
|
|
Acetylcholine |
|||||||
|
Dopamine |
|||||||
|
Endorphins |
|||||||
|
GABA |
|||||||
|
Glutamate |
|||||||
|
Glycine |
|||||||
|
Glutamate |
|||||||
|
Norepinephrine |
|||||||
|
Serotonin |
Notes:
|
Antipsychotics |
||||||||||||||
|
First Generation |
Side Effects (L=Low, M=Moderate, H=High) |
|||||||||||||
|
Generic Name |
Trade Name |
Route(s) of Administration |
LAI option |
Starting Dose |
Half Life |
Indications (s/sx & diagnosis) |
MOA (neurotransmitter effects) |
EPS |
Hyperlipidemia |
T2DM |
Weight Gain |
Cognitive Issue |
Other SE |
Costs |
|
Second Generation |
||||||||||||||
Leave a Reply